Mette Kirstine Agger

Entity
Individual
Business address
C/O Scpharmaceuticals, Inc., 2400 District Avenue Suite 310, 01830 Burlington, MA
Signature Ownership
/s/ John H. Tucker, attorney-in-fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Mette Kirstine Agger has filed 18 SEC EDGAR filings since 11/16/2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing Jun 30, 2025 Jun 26, 2025 001-41855
4 Open Document Open Filing 4 Jun 5, 2025 Jun 3, 2025 001-38293
4 Open Document Open Filing Jun 27, 2024 Jun 25, 2024 001-41855
4 Open Document Open Filing 4 Jun 13, 2024 Jun 11, 2024 001-38293
4 Open Document Open Filing FORM 4 SUBMISSION Feb 6, 2024 Feb 2, 2024 001-41855
3 Open Document Open Filing FORM 3 SUBMISSION Nov 2, 2023 Nov 2, 2023 001-41855
4 Open Document Open Filing FORM 4 SUBMISSION Jun 8, 2023 Jun 6, 2023 001-38293
4 Open Document Open Filing FORM 4 SUBMISSION Jun 11, 2020 Jun 9, 2020 001-38293
4 Open Document Open Filing FORM 4 SUBMISSION Mar 16, 2020 Mar 16, 2020 001-39247
3 Open Document Open Filing FORM 3 SUBMISSION Mar 11, 2020 Mar 11, 2020 001-39247
4 Open Document Open Filing FORM 4 SUBMISSION Jun 20, 2019 Jun 18, 2019 001-38293
4 Open Document Open Filing FORM 4 SUBMISSION May 13, 2019 May 9, 2019 001-38886
4 Open Document Open Filing FORM 4 SUBMISSION May 8, 2019 May 7, 2019 001-38886
3 Open Document Open Filing FORM 3 SUBMISSION May 7, 2019 May 7, 2019 001-38886
4 Open Document Open Filing FORM 4 SUBMISSION Jun 21, 2018 Jun 19, 2018 001-38293
4/A Open Document Open Filing FORM 4/A SUBMISSION Feb 13, 2018 Nov 21, 2017 001-38293
4 Open Document Open Filing FORM 4 SUBMISSION Nov 21, 2017 Nov 21, 2017 001-38293
3 Open Document Open Filing FORM 3 SUBMISSION Nov 16, 2017 Nov 16, 2017 001-38293